In this way, the antagonist HMGA1 and HMGA2 expression pattern observed in esophageal tumors (ESCC and EAC) could result from the activation of specific embrionary-like mechanisms during the distinct development of esophageal squamous cell and adenocarcinoma. Here, HMGA1 is linked to esophageal squamous cell carcinoma.